Ethos Discovery is a stand-alone not for profit created to fulfill unmet needs that hold the potential to improve outcomes for veterinary and human health care patients. It aims to pave the way for innovations that improve diagnostic and treatment options for complex medical conditions such as cancer through scientific studies aligned with innovative platforms at various academic and research institutions.
2015
81-1002068
$10.79 million
This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.
Exploring the use of stem cells for NME treatment in Pugs.
Recent findings offer new hope for dogs with Hemoperitoneum.
Aiming to uncover potential biomarkers and therapeutic targets for canine sepsis.
Research on aggressive cancer in dogs to identify better treatment options.
Learn MoreFocuses on diagnosing and treating Necrotizing meningoencephalitis in Pugs.
Learn MoreExplores new drug therapies that currently lack veterinary approval.
Learn MoreOverall Score
56
64
/100
Program Expense Ratio
91.67%
20
/20
Program Revenue Growth
0.00%
2
/20
Leverage Ratio
0.0000899
20
/20
Working Capital Ratio
12.81
20
/20
Fundraising Efficiency
0
2
/20
Fiscal Year:2022
Source:Source: Self-reported by organization
Category | Amount | Percentage |
---|---|---|
Contributions, Gifts, and Grants | 10.54M | 99.20% |
Program Services | 0 | 0.00% |
Investment Income | 78.1K | 0.74% |
Sales of Non-Inventory Assets | 0 | 0.00% |
Other Notable Sources | 7.325K | 0.07% |
Total Revenue | 10.62M | 100.00% |